Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
The purpose of this study is to compare the maintenance of mild to moderate ulcerative colitis remission with six months of treatment with 1.5 grams of mesalamine pellets each day versus placebo.
Epistemonikos ID: dc7eb198a6d9093c87fdb8ee0c8d4689fc2cffa9
First added on: Mar 23, 2022